DaVita Inc. Stock Underperforms Wednesday When Compared To Competitors Despite Daily Gains

Dow Jones
2025.11.12 22:18
portai
I'm PortAI, I can summarize articles.

DaVita Inc. (DVA) shares rose 1.09% to $123.60 on Wednesday, amid a generally positive market, with the S&P 500 up 0.06% and the Dow Jones up 0.68%. Despite this gain, DaVita's stock remains 31.18% below its 52-week high of $179.60. Compared to competitors, DaVita underperformed as UnitedHealth Group rose 3.55%, while Icon PLC was unchanged and Quest Diagnostics fell 1.06%. Trading volume for DaVita was 919,621, surpassing its 50-day average of 831,289.

This article was automatically generated by MarketWatch using technology from Automated Insights. Shares of DaVita Inc. (DVA) rallied 1.09% to $123.60 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.06% to 6,850.92 and the Dow Jones Industrial Average rising 0.68% to 48,254.82. This was the stock's second consecutive day of gains. DaVita Inc. closed 31.18% below its 52-week high of $179.60, which the company achieved on January 31st. The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as UnitedHealth Group Inc. (UNH) rose 3.55% to $339.06, Icon PLC (ICLR) remained unchanged, and Quest Diagnostics Inc. (DGX) fell 1.06% to $186.85. Trading volume (919,621) eclipsed its 50-day average volume of 831,289. Data source: Dow Jones Market Data, FactSet. Data compiled November 12, 2025. This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. (END) Dow Jones Newswires 11-12-25 1718ET
Source: Dow Jones The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.